TNF and metabolic dysfunction-associated steatotic liver disease: The metformin treatment (only at the higher concentration) resulted in a decrease in the TNFα production to comparable levels in blood cultures derived from all NAFLD patients—regardless of the presence of obesity (P≤0.01) (Fig 2C).